journal article·2025-06

Synthesis of superparamagnetic Fe3O4-PEG400 nanoparticles: Investigation of interaction with proteins and toxicity on cells

Ali Valizadeh, Aboulfazl Mirzapoor, Zahra Hallaji, Mahtab Jahanshah Talab, Bijan Ranjbar

Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (73)

Show source-provided references
1. Theranostic magnetic nanoparticles10.1021/ar200085c ↗
2. Monodisperse magnetic nanoparticles for theranostic applications10.1021/ar200090c ↗
3. Green synthesis of γ-Fe2O3@ SiO2 magnetic nanoparticles functionalized with penciclovir drug: antiproliferative effect, and nucleic acids (DNA and RNA) interaction10.1080/16583655.2024.2357820 ↗
4. CRET-based immunoassay on magnetic beads for selective and sensitive detection of Nanog antigen as a key cancer stem cell marker10.1007/s00604-024-06505-y ↗
5. Nanostructures for the prevention, diagnosis, and treatment of COVID-19: a review
6. Magnetic nanoparticles in targeted drug delivery: a review10.1007/s10948-021-05932-9 ↗
7. Hauptman · Surg. Neurol. Int. · 2010 · 1
8. J.M. Millward, J. Schnorr, M. Taupitz, S. Wagner, J.T. Wuerfel, and C. Infante-Duarte, Iron oxide magnetic nanoparticles highlight early involvement of the choroid plexus in central nervous system inflammation, 5, 2013.10.1042/AN20120081 ↗
9. Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles10.1016/j.biomaterials.2014.12.045 ↗
10. Magnetic nanoparticles for tumor imaging and therapy: a so-called theranostic system10.1007/s11095-013-0982-y ↗
11. Magnetic nanoparticles in cancer therapy and diagnosis10.1002/adhm.201901058 ↗
12. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels10.1126/science.1217815 ↗
13. Nanoparticle-based targeted drug delivery10.1016/j.yexmp.2008.12.004 ↗
14. Multifunctional nanoparticle-mediated combining therapy for human diseases10.1038/s41392-023-01668-1 ↗
15. Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery10.1039/D1NR02065J ↗
16. Interaction of gold nanoparticle with glycated Human serum albumin: impact of morphology and different surface functionalization
17. PEGylated gold nanoparticles: polymer quantification as a function of PEG lengths and nanoparticle dimensions10.1039/C3RA22739A ↗
18. Nanoparticle PEGylation for imaging and therapy10.2217/nnm.11.19 ↗
19. Unfolded protein corona surrounding nanotubes influence the innate and adaptive immune system
20. Nanoparticle protein corona: from structure and function to therapeutic targeting10.1039/D2LC00799A ↗
21. Protein corona: a new approach for nanomedicine design10.2147/IJN.S129300 ↗
22. Nanoparticle interactions with blood proteins and what it means: a tutorial review10.46701/APJBG.2019022019129 ↗
23. The influence of nanostructured materials on biointerfacial interactions10.1016/j.addr.2012.06.001 ↗
24. Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance10.1021/nn400409h ↗
25. In vitro cytotoxicity, antibacterial activity and HSA and ct-DNA interaction studies of chlorogenic acid loaded on γ-Fe2O3@ SiO2 as new nanoparticles10.1080/07391102.2022.2030799 ↗
26. Selenium nanoparticles: synthesis, in-vitro cytotoxicity, antioxidant activity and interaction studies with ct-DNA and HSA, HHb and cyt c serum proteins10.1016/j.btre.2021.e00615 ↗
27. Personalized biocorona as disease biomarker: the challenges and opportunities
28. Efficient loading and entrapment of tamoxifen in human serum albumin based nanoparticulate delivery system by a modified desolvation technique10.1016/j.cherd.2013.11.024 ↗
29. Binding effect of tyrosine-based chiral carbon dots on human serum albumin and lysozyme10.1016/j.molstruc.2024.139041 ↗
30. Cloning, purification and comparative characterization of two digestive lysozymes from Musca domestica larvae10.1590/S0100-879X2008001100005 ↗
31. Design and fabrication of a silver nanocluster-based aptasensor for lysozyme detection10.1007/s11468-019-00954-5 ↗
32. Progress in polymers and polymer composites used as efficient materials for EMI shielding10.1039/D0NA00760A ↗
33. Hydrophilicity and optic property of polyethylene glycol coating on polydimethylsiloxane for fast prototyping and its application to backlight microfluidic chip10.1016/j.surfcoat.2020.125606 ↗
34. The effect of PEGylation on optical and structural properties of ZnO nanostructures for photocatalyst and photodynamic applications
35. An overview of recent advances in polymer composites with improved UV-shielding properties10.1002/app.53693 ↗
36. Development of nanostructured formulation from naringenin and silk fibroin and application for inhibition of lipoxygenase (LOX)10.1039/D3RA02374E ↗
37. M.F. Tai, C.W. Lai, and S.B. Abdul Hamid, Facile synthesis polyethylene glycol coated magnetite nanoparticles for high colloidal stability, , 2016, 2016, 8612505.10.1155/2016/8612505 ↗
38. PEG size effect and its interaction with Fe3O4 nanoparticles synthesized by solvothermal method: morphology and effect of pH on the stability10.1088/2632-959X/ac0596 ↗
39. Comparative Sb (V) removal efficacy of different iron oxides from textile wastewater: effects of co-existing anions and dye compounds10.1007/s11356-023-30771-7 ↗
40. Synthesis and characterization of polyethylene glycol (PEG) coated Fe3O4 nanoparticles by chemical co-precipitation method for biomedical applications10.1016/j.saa.2014.07.059 ↗
41. Kinetic studies on the catalytic degradation of rhodamine b by hydrogen peroxide: effect of surfactant coated and non-coated iron (III) oxide nanoparticles10.3390/polym12102246 ↗
42. Magnetic solid-phase microextraction for lead detection in aqueous samples using magnetite nanoparticles
43. Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line10.3109/21691401.2014.934456 ↗
44. Characterization and synthesis of magnetite nanoparticles by innovative sonochemical method10.1016/j.mspro.2015.11.022 ↗
45. Fabrication of Cu2ZnSnS4 light absorber using a cost-effective mechanochemical method for photovoltaic applications10.3390/ma15051708 ↗
46. Thermoresponsive magnetic colloids10.1007/s00396-007-1667-z ↗
47. Highly water-soluble nanocrystal powders of magnetite and maghemite coated with gluconic acid: preparation, structure characterization, and surface coordination10.1016/j.jcis.2010.10.049 ↗
48. Design of carboxylated Fe3O4/poly (styrene-co-acrylic acid) ferrofluids with highly efficient magnetic heating effect10.1016/j.colsurfa.2011.02.050 ↗
49. Syntheses of ferrofluids using polyethylene glycol (PEG) coated magnetite (Fe3O4), citric acid, and water as the working liquid in a cylindrical heat pipe
50. PEGylated magnetic nanoparticles (PEG@ Fe3O4) as cost effective alternative for oxidative cyanation of tertiary amines via CH activation10.1016/j.apcata.2015.03.018 ↗
51. Fabrication of magnetic Fe3O4/polypyrrole/carbon black nanocomposite for effective uptake of congo red and methylene blue dye: adsorption investigation and mechanism10.1007/s10924-022-02663-3 ↗
52. Modified magnetic nanoparticles by PEG-400-immobilized Ag nanoparticles (Fe3O4@ PEG–Ag) as a core/shell nanocomposite and evaluation of its antimicrobial activity10.2147/IJN.S161002 ↗
53. Fe 3 O 4@ PEG core/shell nanoparticles as magnetic nanocatalyst for acetylation of amines and alcohols using ultrasound irradiations under solvent-free conditions10.1007/s11164-018-3614-7 ↗
54. Synthesis, surface modification and characterisation of biocompatible magnetic iron oxide nanoparticles for biomedical applications10.3390/molecules18077533 ↗
55. Circular dichroism techniques: biomolecular and nanostructural analyses-a review10.1111/j.1747-0285.2009.00847.x ↗
56. An experimental investigation on the influence of various buffer concentrations, osmolytes and gold nanoparticles on lysozyme: spectroscopic and calorimetric study10.1016/j.ijbiomac.2020.12.208 ↗
57. Conformation and activity of lysozyme on binding to two types of gold nanorods: a comparative study10.1016/j.ijbiomac.2012.04.020 ↗
58. Structural studies of hen egg-white lysozyme dimer: comparison with monomer
59. Roles of trehalose and magnesium sulfate on structural and functional stability of firefly luciferase10.1016/j.molcatb.2009.09.015 ↗
60. A new approach to the calculation of secondary structures of globular proteins by optical rotatory dispersion and circular dichroism10.1016/S0006-291X(71)80225-5 ↗
61. Structural characteristics of thermostable immunogenic outer membrane protein from Salmonella enterica serovar Typhi10.1007/s00253-013-5123-3 ↗
62. Conformation and thermal denaturation of apocalmodulin: role of electrostatic mutations10.1021/bi962538g ↗
63. Cryo-EM structure of a lysozyme-derived amyloid fibril from hereditary amyloidosis10.1038/s41467-024-54091-7 ↗
64. Combining structure and dynamics: non-denaturing high-pressure effect on lysozyme in solution
65. pH-dependent conformational transitions in conalbumin (ovotransferrin), a metalloproteinase from hen egg white10.1007/s12013-011-9237-x ↗
66. One-pot solid phase pyrolysis synthesis of highly fluorescent nitrogen-doped carbon dots and the interaction with human serum albumin10.1016/j.jlumin.2017.12.029 ↗
67. Correlation between adsorption isotherms, thin liquid films and foam properties of protein/surfactant mixtures: lysozyme/C10DMPO and lysozyme/SDS10.1016/j.colsurfa.2007.09.026 ↗
68. Dopamine-conjugated apoferritin protein nanocage for the dual-targeting delivery of epirubicin
69. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture10.3390/ijms13055554 ↗
70. Synthesis and cytotoxicity study of magnetite nanoparticles coated with polyethylene glycol and sorafenib–zinc/aluminium layered double hydroxide10.3390/polym12112716 ↗
71. Supermagnetic Fe3O4-PEG nanoparticles combined with NIR laser and alternating magnetic field as potent anti-cancer agent against human ovarian cancer cells
72. Fe 3 O 4 nanoparticles capped with PEG induce apoptosis in breast cancer AMJ13 cells via mitochondrial damage and reduction of NF-κb translocation10.1007/s10904-020-01791-4 ↗
73. Effects of PEGylated Fe–Fe3O4 core-shell nanoparticles on NIH3T3 and A549 cell lines10.1016/j.heliyon.2019.e03124 ↗